Literature DB >> 35094349

Adeno-Associated Viral Vector Immobilization and Local Delivery from Bare Metal Surfaces.

Ben B Pressly1, Bahman Hooshdaran1, Ivan S Alferiev1,2, Michael Chorny1,2, Robert J Levy1,2, Ilia Fishbein3,4.   

Abstract

Spatially and temporally controlled delivery of biologicals, including gene vectors, represents an unmet need for regenerative medicine and gene therapy applications. Here we describe a method of reversible attachment of serotype 2 adeno-associated viral vectors (AAV2) to metal surfaces. This technique enables localized delivery of the vector to the target cell population in vitro and in vivo with the subsequent effective transduction of cells adjacent to the metal substrate. The underlying bioengineering approach employs coordination chemistry between the bisphosphonic groups of polyallylamine bisphosphonates and the metal atoms on the surface of metallic samples. Formation of a stable polybisphosphonate monolayer with plentiful allyl-derived amines allows for further chemical modification to consecutively append thiol-modified protein G, an anti-AAV2 antibody, and AAV2 particles. Herein we present a detailed protocols for the metal substrate modification, for the visualization of the metal surface-immobilized vector using direct and indirect fluorescent AAV2 labeling and scanning electron microscopy, for quantification of the surface-immobilized vector load with RT-PCR, and for the localized vector transduction in vitro and in vivo.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  AAV2 labeling; Metal substrate; Serotype 2 adeno-associated viral vectors; The metal surface-immobilized vector

Mesh:

Substances:

Year:  2022        PMID: 35094349      PMCID: PMC9250281          DOI: 10.1007/978-1-0716-1811-0_32

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  18 in total

1.  The identity of the cell adhesive protein substrate affects the efficiency of adeno-associated virus reverse transduction.

Authors:  Kellie I McConnell; Eric J Gomez; Junghae Suh
Journal:  Acta Biomater       Date:  2012-07-06       Impact factor: 8.947

2.  Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents.

Authors:  Ilia Fishbein; Ivan S Alferiev; Origene Nyanguile; Richard Gaster; John M Vohs; Gordon S Wong; Howard Felderman; I-Wei Chen; Hoon Choi; Robert L Wilensky; Robert J Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

Review 3.  Adeno-associated virus vector as a platform for gene therapy delivery.

Authors:  Dan Wang; Phillip W L Tai; Guangping Gao
Journal:  Nat Rev Drug Discov       Date:  2019-05       Impact factor: 84.694

Review 4.  Thoughts on Chemistry, Manufacturing, and Control of Cell Therapy Products for Clinical Application.

Authors:  Wei Wei; Jianhui Luo
Journal:  Hum Gene Ther       Date:  2018-11-13       Impact factor: 5.695

5.  Reverse transduction can improve efficiency of AAV vectors in transduction-resistant cells.

Authors:  Esther J Lee; Tawana M Robinson; Jeffrey J Tabor; Antonios G Mikos; Junghae Suh
Journal:  Biotechnol Bioeng       Date:  2018-10-01       Impact factor: 4.530

6.  Surface adsorption of DNA to tissue engineering scaffolds for efficient gene delivery.

Authors:  Jae-Hyung Jang; Zain Bengali; Tiffany L Houchin; Lonnie D Shea
Journal:  J Biomed Mater Res A       Date:  2006-04       Impact factor: 4.396

7.  LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.

Authors:  S Hacein-Bey-Abina; C Von Kalle; M Schmidt; M P McCormack; N Wulffraat; P Leboulch; A Lim; C S Osborne; R Pawliuk; E Morillon; R Sorensen; A Forster; P Fraser; J I Cohen; G de Saint Basile; I Alexander; U Wintergerst; T Frebourg; A Aurias; D Stoppa-Lyonnet; S Romana; I Radford-Weiss; F Gross; F Valensi; E Delabesse; E Macintyre; F Sigaux; J Soulier; L E Leiva; M Wissler; C Prinz; T H Rabbitts; F Le Deist; A Fischer; M Cavazzana-Calvo
Journal:  Science       Date:  2003-10-17       Impact factor: 47.728

8.  Adenoviral vector tethering to metal surfaces via hydrolyzable cross-linkers for the modulation of vector release and transduction.

Authors:  Ilia Fishbein; Scott P Forbes; Michael Chorny; Jeanne M Connolly; Richard F Adamo; Ricardo A Corrales; Ivan S Alferiev; Robert J Levy
Journal:  Biomaterials       Date:  2013-06-15       Impact factor: 12.479

Review 9.  Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders.

Authors:  Alireza Shahryari; Marie Saghaeian Jazi; Saeed Mohammadi; Hadi Razavi Nikoo; Zahra Nazari; Elaheh Sadat Hosseini; Ingo Burtscher; Seyed Javad Mowla; Heiko Lickert
Journal:  Front Genet       Date:  2019-09-25       Impact factor: 4.599

Review 10.  Engineering targeted viral vectors for gene therapy.

Authors:  Reinhard Waehler; Stephen J Russell; David T Curiel
Journal:  Nat Rev Genet       Date:  2007-07-03       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.